Company Directory › Robotics & hardware › MMI (Medical Microinstruments)
Profile not yet claimed. This profile was compiled by GlobleMatch from public sources on 6 November 2026. It has not been reviewed or endorsed by MMI (Medical Microinstruments), and a listing does not imply a partnership with GlobleMatch. If you represent MMI (Medical Microinstruments), you can claim this profile to verify and manage it — or request a correction or removal.
Directory Listing · United States
MMI (Medical Microinstruments)Not yet claimed
MMI (Medical Microinstruments) is a surgical robotics company dedicated to microsurgery and supermicrosurgery — open surgery performed at a scale smaller than the unaided human hand can reliably manage.
About MMI (Medical Microinstruments)
MMI (Medical Microinstruments) is a surgical robotics company dedicated to microsurgery and supermicrosurgery — open surgery performed at a scale smaller than the unaided human hand can reliably manage. Its product is the Symani Surgical System, a robotic platform that combines wristed microinstruments with tremor-reduction and motion-scaling technology, letting surgeons operate on extremely small blood vessels, lymphatic structures and other delicate soft tissue with greater precision, consistency and control. Its NanoWrist instruments carry what the company describes as the world’s smallest robotic wrist, replicating natural hand movements for tasks such as dissection and anastomosis. The system is authorised for use in the United States by the FDA and is a CE-marked medical device in Europe, and the company supports it with an active clinical-evidence programme, including studies in reconstructive surgery, lymphedema treatment and other complex indications.
The company was founded in 2015 near Pisa, Italy, where Symani systems are still manufactured, and its headquarters are now in Jacksonville, Florida, from where it is expanding commercialisation in the United States and other key global markets. For hospitals and partners, MMI is the specialist option in robotic microsurgery: a single-purpose platform built for the micro-scale procedures that general surgical robots are not designed to perform.
Products & services
- Symani Surgical System — robotic platform for microsurgery and supermicrosurgery in open surgery
- NanoWrist wristed microinstruments for dissection, suturing and anastomosis at micro scale
- Tremor-reduction and motion-scaling technology for soft-tissue open surgery
- Clinical study and evidence programmes supporting indication expansion (including reconstructive, lymphatic and other complex procedures)
Questions partners ask
MMI (Medical Microinstruments) is a surgical robotics company dedicated to microsurgery and supermicrosurgery — open surgery performed at a scale smaller than the unaided human hand can reliably manage. Its listed range includes Symani Surgical System, NanoWrist wristed microinstruments for dissection, suturing and anastomosis at micro scale, Tremor-reduction and motion-scaling technology for soft-tissue open surgery, Clinical study and evidence programmes supporting indication expansion.
MMI (Medical Microinstruments) is headquartered in Jacksonville, Florida, United States. Its founding is recorded as: 2015 (near Pisa, Italy, per the company’s official press releases).
Approximately $345M total investment to date (company-stated, official investors page: $24M Series A, approximately $75M Series B plus a $12M Series B extension, $110M Series C in 2024, and $125M Series D in 2026).
GlobleMatch Trust Signals
A directory that doesn’t sell stars. Trust Signals are built only from verifiable facts — never from anonymous ratings, and never for sale. There is no single hidden score.
| Public information coverage | 8 of 9 fields on the standard profile could be filled from public sources.This counts how much public information exists about the company — not how good the company is. The nine fields are listed in the methodology. Claiming the profile lets the company complete the remaining fields itself. |
|---|---|
| Last verified | 6 November 2026 — facts on this profile were checked against the sources listed below. Profiles are re-checked on a published 90-day cycle; this date is never quietly refreshed. |
Claim this profile to unlock response record, directory tenure and peer endorsements. The full methodology — what each signal measures and how it is calculated — is published in the Trust Signals methodology, including a change log.
Sources & verification
- Company website — mmimicro.com (official site: profile facts, headquarters, markets and product range). Checked 6 November 2026.
- Figures described in this profile as company-stated come from the company’s own public materials and were not independently audited by GlobleMatch.
Facts last verified: 6 November 2026. Something wrong? A listed company can request a correction or removal at any time; verified requests are actioned.
Related companies
More in Robotics & hardware: Dexory (autonomous inventory robots & data platform, United Kingdom) · Humanoid (industrial humanoid robots and embodied ai platform, United Kingdom) · Covariant (ai foundation models for robotic picking and warehouse automation, United States)
Robotics on GlobleMatch: the GlobleMatch Robotics 100 programme tracks leading robotics companies worldwide, and claimed directory profiles can be considered for its seats.
Profile facts
| Headquarters | Jacksonville, Florida, United States (5022 Gate Parkway, Building 500, Jacksonville, FL 32256, per the company’s official privacy notice; secondary seat near Pisa, Italy — the company was founded near Pisa in 2015 and Symani is manufactured in Pisa, Italy) |
|---|---|
| Country | United States |
| Industry | Surgical robotics — robotic microsurgery and supermicrosurgery systems |
| Founded | 2015 (near Pisa, Italy, per the company’s official press releases) |
| Company size | — (not publicly disclosed; left blank rather than guessed) |
| Markets served | Hospitals and surgical centres in the United States and international markets; Symani is FDA-authorised in the US and CE-marked in Europe, with clinical indications varying by geography |
| Official website | mmimicro.com |
| Public funding | Approximately $345M total investment to date (company-stated, official investors page: $24M Series A, approximately $75M Series B plus a $12M Series B extension, $110M Series C in 2024, and $125M Series D in 2026) |
| Profile status | Not yet claimed |
| Facts last verified | 6 November 2026 |
Represent MMI (Medical Microinstruments)?
Claiming this profile is free. Once your claim is verified, you get:
- Verified badge — on this profile
- Edit rights — intro, logo, photos, website and contact button
- Correction channel — for any fact that is wrong
- Free AI Search Visibility Snapshot — the full report on how AI search engines describe your company
- GlobleMatch badge pack — for your own website
- “Recently Claimed” announcement — in the directory
- Path to a showcase profile — and Founding Claimer highlight for early claimers
Verified with a company-domain email or proof on your official website or social profile. One claim per company; benefits activate after verification.
Not your company, or want it removed? Request a correction or removal.